Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Bausch and Lomb
Bausch and Lomb
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
Valeant Pharmaceuticals to acquire Synergetics USA
Acquisition will further enhance Bausch + Lomb's presence around the world in the rapidly evolving field of vitreoretinal surgery
Finance
Valeant to purchase Bausch + Lomb for US$8.7bn
Will establish Valeant as a global leader in eye health and dermatology
Finance
Bausch + Lomb to purchase ISTA Pharmaceuticals for US$500m
Adds anti-inflammatory, allergy and glaucoma products to portfolio
Finance
Bausch + Lomb launches pharmaceuticals business in India
Partnership with Micro Labs will provide high quality manufacturing capabilities
Finance
Bausch + Lomb names global president, pharmaceuticals
Daniel Wechsler joins from Merck & Co
Research & Development
Bausch + Lomb wins rights to NCX 116
Worldwide rights for the NCX 116 compound have been granted to Bausch + Lomb for the treatment of glaucoma and ocular hypertension.
Media
Bausch & Lomb sets up global pharma hq in New Jersey
<p>Bausch & Lomb is to open its global pharmaceutical headquarters in Madison, US on Monday, 20 July.</p>
Subscribe now